S
Sarwa Darwish Murad
Researcher at Erasmus University Rotterdam
Publications - 100
Citations - 6994
Sarwa Darwish Murad is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Liver transplantation & Population. The author has an hindex of 34, co-authored 93 publications receiving 5930 citations. Previous affiliations of Sarwa Darwish Murad include University of Western Ontario & Erasmus University Medical Center.
Papers
More filters
Journal ArticleDOI
The Rotterdam Study: Objectives and design update
Albert Hofman,Guy Brusselle,Sarwa Darwish Murad,Cornelia M. van Duijn,Oscar H. Franco,André Goedegebure,M. Arfan Ikram,Caroline C W Klaver,Tamar Nijsten,Robin P. Peeters,Bruno H. Ch. Stricker,Henning Tiemeier,André G. Uitterlinden,Meike W. Vernooij +13 more
TL;DR: The rationale of the study and its design is given, and a summary of the major findings and an update of the objectives and methods are presented.
Journal ArticleDOI
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
Sarwa Darwish Murad,Aurélie Plessier,Manuel Hernández-Guerra,Federica Fabris,Chundamannil E. Eapen,Matthias J. Bahr,Jonel Trebicka,Isabelle Morard,L Lasser,Jörg Heller,Antoine Hadengue,Philippe Langlet,H.P. Miranda,Massimo Primignani,Elwyn Elias,Frank W.G. Leebeek,Frits R. Rosendaal,Juan Carlos García-Pagán,D. Valla,Harry L.A. Janssen +19 more
TL;DR: Most patients with Budd-Chiari syndrome have at least 1 thrombotic risk factor, and many have more than 1; myeloproliferative disorders are most common; one- and 2-year survival rates are good with contemporary management, which includes noninvasive therapies and invasive techniques.
Journal ArticleDOI
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
Sarwa Darwish Murad,W. Ray Kim,Denise M. Harnois,David D. Douglas,James R. Burton,Laura Kulik,Jean F. Botha,Joshua D. Mezrich,William C. Chapman,Jason J. Schwartz,Johnny C. Hong,Jean C. Emond,Hoonbae Jeon,Charles B. Rosen,Gregory J. Gores,Julie K. Heimbach +15 more
TL;DR: Patients with perihilar cholangiocarcinoma who were treated with neoadjuvant therapy followed up by liver transplantation at 12 US centers had a 65% rate of recurrence-free survival after 5 years, showing this therapy to be highly effective.
Journal ArticleDOI
The Rotterdam Study: 2018 update on objectives, design and main results.
M. Arfan Ikram,Guy Brusselle,Guy Brusselle,Sarwa Darwish Murad,Cornelia M. van Duijn,Oscar H. Franco,André Goedegebure,Caroline C W Klaver,Tamar Nijsten,Robin P. Peeters,Bruno H. Stricker,Henning Tiemeier,André G. Uitterlinden,Meike W. Vernooij,Albert Hofman,Albert Hofman +15 more
TL;DR: The rationale of the study and its design is given, a summary of the major findings and an update of the objectives and methods are presented and the cohort is being expanded by persons aged 40 years and over.
Journal ArticleDOI
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases
Jean-Jacques Kiladjian,Francisco Cervantes,Franck W. G. Leebeek,Christophe Marzac,Bruno Cassinat,Sylvie Chevret,Dominique Cazals-Hatem,Aurélie Plessier,Juan Carlos García-Pagán,Sarwa Darwish Murad,Sebastián Raffa,Harry L.A. Janssen,Claude Gardin,Sophie Cereja,Carole Tonetti,Stéphane Giraudier,Bertrand Condat,Nicole Casadevall,Pierre Fenaux,Dominique Valla +19 more
TL;DR: The results suggest that JAK2V617F testing should replace BM investigations as initial test for MPD in patients with SVT, and that current therapy appears to offset deleterious effects of MPD on the medium-term outcome.